tetano
Editor, Senior Moderator
Oxf Med Case Reports
. 2021 Dec 28;2021(11-12)
mab121.
doi: 10.1093/omcr/omab121. eCollection Nov-Dec 2021.
Bilateral renal infarction with COVID-19 pneumonia: a case report
Kundan Jana[SUP] 1 [/SUP], Kalyana C Janga[SUP] 1 [/SUP], Sheldon Greenberg[SUP] 1 [/SUP], Kamlesh Kumar[SUP] 1 [/SUP]
Affiliations
Abstract
Acute renal infarction is a rare and often underdiagnosed condition with estimated incidence of 0.5-1.5%. Coronavirus disease 2019 (COVID-19) has been shown to cause a hypercoagulable state in patients leading to arterial and venous thromboembolism. Renal infarction as a consequence of COVID-associated coagulopathy has been reported, sometimes resulting in acute kidney injury. Most of the patients so far reported had other existing comorbidities and risk factors that compounded the risk of precipitating an infarction. Here, we present a 37-year-old, the youngest patient reported so far, with no pre-existing comorbidities or risk factors, who developed bilateral renal infarction with COVID-19 pneumonia. The patient was treated with anticoagulation for renal infarction and discharged on apixaban. Anticoagulation is an important part of current treatment strategies for COVID-19 pneumonia and should extend beyond the acute phase of the disease to prevent long-term sequelae, especially in young patients.
. 2021 Dec 28;2021(11-12)
mab121.doi: 10.1093/omcr/omab121. eCollection Nov-Dec 2021.
Bilateral renal infarction with COVID-19 pneumonia: a case report
Kundan Jana[SUP] 1 [/SUP], Kalyana C Janga[SUP] 1 [/SUP], Sheldon Greenberg[SUP] 1 [/SUP], Kamlesh Kumar[SUP] 1 [/SUP]
Affiliations
- PMID: 34987851
- PMCID: PMC8713579
- DOI: 10.1093/omcr/omab121
Abstract
Acute renal infarction is a rare and often underdiagnosed condition with estimated incidence of 0.5-1.5%. Coronavirus disease 2019 (COVID-19) has been shown to cause a hypercoagulable state in patients leading to arterial and venous thromboembolism. Renal infarction as a consequence of COVID-associated coagulopathy has been reported, sometimes resulting in acute kidney injury. Most of the patients so far reported had other existing comorbidities and risk factors that compounded the risk of precipitating an infarction. Here, we present a 37-year-old, the youngest patient reported so far, with no pre-existing comorbidities or risk factors, who developed bilateral renal infarction with COVID-19 pneumonia. The patient was treated with anticoagulation for renal infarction and discharged on apixaban. Anticoagulation is an important part of current treatment strategies for COVID-19 pneumonia and should extend beyond the acute phase of the disease to prevent long-term sequelae, especially in young patients.